팝업레이어 알림


Nexmos

The Innovative DNA Aptamer Bio Technology Pioneer

Aptamin

World’s First Antioxidant DNA Aptamer Meta-Platform

Therapeutics

BBB Shuttle Aptamer & Degenerative Brain Disease Research

Healthcare

Healthy Lives & Brighter Future with Aptamin®

Aptamin®

Another DNA Aptamer that the intellectual property rights
registered and owned by Nexmos is actively, and stably delivering
antioxidant and maximizing (boost) the efficacies via ROS removal,
and unexpectable synergy effects of DNA itself.

View more

Therapeutics

The new generation of DNA Aptamer technology, defined by
Nexmos, is adaptable for new possibilities of incurable diseases,
as BBB Shuttle Aptamer and degenerative brain diseases’
candidate substances.

View more

Healthcare

Nexmos experts unveiled the confirmed efficacies of Aptamin®, and
those create a new era of commercial DNA for innovative personal
care and dietary supplements.

View more

About us

Flying Towards To The Next Cosmos

A global therapeutics and healthcare market
pioneer based on unrivaled world’s first
commercial DNA Aptamer

Nexmos is an innovative, biotechnology R&D company with a
brand-new DNA meta-platform protected by global intellectual
properties. Founded in 2014, the company has developed
DNA-based Aptamer technology with registered related patents
and worked on the healthcare and therapeutics industry using its
technology.

View more